Bioventus Inc (BVS)

Finanzdaten der Bioventus Inc-Aktie (BVS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-07-01	2023-04-01	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	12.11% 135.42	120.79	137.07	119.06	125.83
Cost Of Revenue	17.11% 49.12	41.94	47.95	45.14	51.65
Gross Profit	9.45% 86.30	78.85	89.12	73.92	74.19
Operating Expenses	11.39% 85.14	76.43	82.37	165.98	99.62
Benefits Costs and Expenses	11.51% 143.83	128.99	141.42	219.22	175.55
Costs And Expenses	11.51% 143.83	128.99	141.42	219.22	175.55
Depreciation and Amortization	9.28% 2.102	2.317	2.294	2.129	7.761
Operating Income/Loss	51.82% 1.165	2.418	6.75	-92.06	-25.43
Nonoperating Income/Loss	9.78% -9.571	-10.61	-11.10	-8.106	-24.28
Income/Loss From Continuing Operations Before Tax	2.62% -8.406	-8.191	-4.35	-100.16	-49.71
Income Tax Expense/Benefit	225.00% -0.75	0.60	0.381	-0.146	-4.841
Income/Loss From Continuing Operations After Tax	12.91% -7.656	-8.791	-4.731	-100.02	-44.87
Income/Loss From Discontinued Operations, Net Of Tax	-	-	-	-74.43	-
Net Income/Loss	12.91% -7.656	-8.791	-4.731	-174.45	-44.87
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	4.84% -1.56	-1.488	-1.05	-20.36	-12.94
Basic Average Shares	99.76% 0.1529	62.82	62.55	62.12	0.1802
Diluted Average Shares	99.76% 0.1529	62.82	62.55	62.12	0.1802
Basic Earnings Per Share	25.00% -0.09	-0.12	-0.06	-2.24	-0.52
Diluted Earnings Per Share	25.00% -0.09	-0.12	-0.06	-2.24	-0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-